Austar Lifesciences Debt 2024

Austar Lifesciences Aktienanalyse

What does Austar Lifesciences do?

Austar Lifesciences Ltd is an Indian manufacturer of pharmaceutical products and medical devices. The company was founded in 2003 by Mr. Sudhir Taneja and is headquartered in the city of Mohali in the state of Punjab. Since its inception, the company has continuously evolved and is now a leading brand in the Indian healthcare market. Austar Lifesciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Austar Lifesciences's Debt Structure

Austar Lifesciences's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Austar Lifesciences's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Austar Lifesciences’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Austar Lifesciences’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Austar Lifesciences stock

What is the debt of Austar Lifesciences this year?

Austar Lifesciences has a debt level of 496.18 CNY this year.

What was the debt of Austar Lifesciences compared to the previous year?

The debt of Austar Lifesciences has increased by 144.55% compared to the previous year increased.

What are the consequences of high debt for investors in Austar Lifesciences?

High debt can pose a risk for investors of Austar Lifesciences, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Austar Lifesciences?

Low debt means that Austar Lifesciences has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Austar Lifesciences affect the company?

An increase in debt of Austar Lifesciences can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Austar Lifesciences affect the company?

A reduction in debt of Austar Lifesciences can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Austar Lifesciences?

Some factors that can influence the debt of Austar Lifesciences include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Austar Lifesciences so important for investors?

The debts of Austar Lifesciences are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Austar Lifesciences take to change the debt?

To change the debt, Austar Lifesciences can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Austar Lifesciences pay?

Over the past 12 months, Austar Lifesciences paid a dividend of 0.05 CNY . This corresponds to a dividend yield of about 7.18 %. For the coming 12 months, Austar Lifesciences is expected to pay a dividend of 0 CNY.

What is the dividend yield of Austar Lifesciences?

The current dividend yield of Austar Lifesciences is 7.18 %.

When does Austar Lifesciences pay dividends?

Austar Lifesciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Austar Lifesciences?

Austar Lifesciences paid dividends every year for the past 0 years.

What is the dividend of Austar Lifesciences?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Austar Lifesciences located?

Austar Lifesciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Austar Lifesciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Austar Lifesciences from 6/26/2015 amounting to 0.05 CNY, you needed to have the stock in your portfolio before the ex-date on 5/19/2015.

When did Austar Lifesciences pay the last dividend?

The last dividend was paid out on 6/26/2015.

What was the dividend of Austar Lifesciences in the year 2023?

In the year 2023, Austar Lifesciences distributed 0 CNY as dividends.

In which currency does Austar Lifesciences pay out the dividend?

The dividends of Austar Lifesciences are distributed in CNY.